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Metastatic Thymoma of the Breast
Breast metastasis from nonmammary malignant neoplasms is uncommon, and
it accounts for approximately 2% of all breast tumors. Distant metastasis of thy-
moma is very rare, and especially to extrathorcic areas. We report a female who
had a metastatic thymoma in her breast 20 years after undergoing resection for a
non-invasive thymoma. She presented with a palpable mass in her left breast.
Mammography and ultrasonogram showed a lobular mass at the anterior glandu-
lar portion. Histological examination after surgical excision revealed a metastatic
thymoma. 
he breast is the most common site of primary malignant tumors in adult
women and it is unusual site for nonmammary malignancies (1). The
incidence of breast metastasis from other organs ranges from 1.7% to
6.6% in autopsy series and is even lower (1.2 2.7%) in clinical and cytological series
(2, 3). Yet the surgical planning and follow-up change depending on if a tumor is a
primary or metastatic breast tumor, and it is the important to recognize the clinical and
imaging differences between them.
Thymoma is usually a slow-growing tumor. Although intrathoracic recurrence
sometimes occurs in patients with invasive thymoma, few cases of distant metastasis
following resection of a non-invasive thymoma have been reported (4), and metastatic
thymic tumor to the breast is extremely rare indeed (5).
We describe here the radiological and histological findings of metastatic thymoma of
the breast. 
CASE REPORT
A 49-year-old woman visited our hospital for a palpable mass in her left breast.
Physical examination revealed a 2-cm firm mass in the upper outer quadrant of the left
breast. There was no palpable axillary lymphadenopathy. 
She had a history of operation 20 years ago for mediastinal non-invasive thymoma
without metastasis. She developed cough and blood tinged sputum two years
previously. Chest X-ray and CT scan showed a mass in the right upper lung. After one
year, with the worsening symptoms and increasing size of mass, she underwent
lobectomy for the right upper lung lesion and this was diagnosed as metastatic
thymoma, type B3 with pleural invasion. She also received radiation therapy after
lobectomy. Six months after radiation therapy, a palpable mass developed in her left
breast. The patient did not experience any symptoms of myasthenia gravis.
Mammography showed a high-density mass, 2.3 cm, with irregular shaped in the left
upper outer breast (Fig. 1). On ultrasound (US), a hypoechoic mass, 2.6 cm, with
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e-mail: claudel@skku.eduirregular shaped was noted in the junction of the breast
parenchyma and the subcutaneous fat layer (Fig. 2A).
Color Doppler US showed increased vascularity within the
mass (Fig. 2B). US-guided core needle biopsy and surgical
excision showed a metastatic thymoma of the B3 type. On
microscopic examination, the tumor was predominantly
composed of solid nests of oval or polygonal epithelial cells
separated by dense fibrous septa. The nests were admixed
with a minor component of lymphocytes, resulting in a
lobular sheet-like growth of the neoplastic epithelial cells
(Fig. 3A). On immunohistochemistry staining, the tumor
cells were positive for CK (AE1/AE3) and CD99, and TdT-
positive thymocytes were found in the tumor cell nests
(Fig. 3B). 
After that, she underwent additional excision for a newly
developed tiny nodule in the left breast, which was also a
metastatic nodule. Additional chemotherapy or radiation
therapy was not considered. 
DISCUSSION
Metastatic disease to the breast from nonmammary
primary lesions is rather unusual. The breast had resistance
to metastasis from extramammary malignancy because it
contained large areas of fibrous tissue with a relatively
poor blood supply (6); however, virtually any malignancy
can metastasize to the breast. The most frequent source of
such metastasis was reported to be melanoma, but a wide
variety of other tumors may secondarily involve the
breast, including leukemia, lymphoma, carcinomas from
ovary, lung, esophagus, stomach, colon, liver, cervix and
the nasopharynx, uterine leiomyosarcoma and embryonal
rhabdomyosarcoma (1, 2).
Reports about metastatic breast tumors from the thymus
are extremely rare and there is one report about poorly
differentiated thymic carcinoma with invasion and distant
metastasis to the breast that was found within six months
during the period of adjuvant chemotherapy (5). Our case
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Fig. 2. Ultrasound (A) of her left breast shows a hypoechoic mass, 2.6-cm, with irregular shaped, located in the junction of the breast
parenchyma and the subcutaneous fat layer. Color Doppler ultrasound (B) shows increased vascularity within the mass. 
AB
Fig. 1. A 49-year-old female patient with a palpable mass in her
left breast. Mammography demonstrates a high-density mass
with irregular shaped, measuring 2.3 cm, without calcification in
the upper outer quadrant of the left breast. initially showed non-invasive thymoma without metastasis,
and the women experienced more than 18 years of a
disease-free period until detection of the distant metastasis.
Metastatic lesions to breast can be single or multiple,
unilateral or bilateral. They are usually round or oval
masses with well-circumscribed to ill-defined margins on
mammography (7). The US findings are round, hypoechoic
lesions in a superficial location without acoustic shadowing
or microcalcification (1).
Our case was a well-defined, lobular hypoechoic solid
mass and it was located at the junction of the breast
parenchyma and the subcutaneous fat tissue. There was no
spiculation, thick hyperechoic halo, nor parenchymal
distortion around the mass that would suggest primary
malignancy of the breast. As compared with the usual
metastatic masses, our case showed a more lobulating
contour and heterogeneous internal echo texture on US,
and this may reflect the growth pattern of the primary
tumor. Histological type B thymoma grows in expansile
sheets or it more often displays a lobular architecture that
recapitulates the normal thymic cortex (8). However, the
radiological findings of extrathoracic solid organ metastasis
from a thymic epithelial tumor are not known, and the one
previously reported case showed slightly different features
from ours. 
Thymic epithelial tumor is a distinctive pathologic entity
that exhibits variable histologic features and heteroge-
neous oncologic behavior. Recently, a new classification of
the World Health Organization that s based on the
morphology of the epithelial cells as well as on the
lymphocyte-to-epithelial cell ratio has been adopted
because of the good correlation between the histologic
appearance and the oncologic behavior (9). According to
the WHO classification, our case is a B3 thymoma and it is
a high-risk thymoma with a 30% incidence of invasive
tumor (10).
Metastases from thymoma usually occur within the
thorax and only 3% of patients have extrathoracic lesions
(11). One study reported that the mean interval between
detecting primary tumor and detecting extrathoracic
metastasis was nine years, and the maximum interval was
21 years (11). This suggests that thymic tumor can metasta-
size even a long time after treatment of the initial mediasti-
nal mass, along with it growing very slowly. Therefore,
when the patient with a breast mass has a history of thymic
tumor, metastasis from thymic tumor should be included in
a differential diagnosis regardless of the initial low
malignant potential of thymic tumor or the long disease-
free period. 
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Fig. 3. Photomicrograph (A) discloses lobular growth of the oval to polygonal cells that are separated by dense fibrous stroma
(Hematoxylin & Eosin staining,  100). Immunohistochemical staining (B) demonstrates the presence of thymocytes in the tumor cell
nests (CD99,  100).
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